Acute myocardial infarction: Safety of cardiac MR imaging after percutaneous revascularization with stents

Radiology

Volumn 240, Issue 3, 2006, Pages 674-680

  Patel, Manesh R ^a   Albert, Timothy S E ^a   Kandzari, David E ^a   Honeycutt, Emily F ^a   Shaw, Linda K ^a   Sketch Jr , Michael H ^a   Elliott, Michael D ^a   Judd, Robert M ^a   Kim, Raymond J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOVERSETAMIDE; PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RETROSPECTIVE STUDIES; STENTS;

EID: 33747603475     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2403050740     Document Type: Article

References (29)

1. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52.
2. Van Belle E, Tio FO, Couffinhal T, Maillard L, Passeri J, Isner JM. Stent, endothelialization: time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 1997;95:438-448.
3. Schneider DB, Dichek DA. Intravascular stent endothelialization: a goal worth pursuing? Circulation 1997;95:308-310.
4. Strohm O, Kivelitz D, Gross W, et al. Safety of implantable coronary stents during 1H-magnetic resonance imaging at 1.0 and 1.5 T. J Cardiovasc Magn Reson 1999;1:239-245.
5. Hug J, Nagel E, Bornstedt A, Schnackenburg B. Oswald H, Fleck E. Coronary arterial stents: safety and artifacts during MR imaging. Radiology 2000;216:781-787.
6. Kramer CM, Rogers WJ Jr, Pakstis DL. Absence of adverse outcomes after magnetic resonance imaging early after stent placement for acute myoeardial infarction: a preliminary study. J Cardiovasc Magn Reson 2000;2:257-261.
7. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eltiting stent implantation. Circulation 2004;109:1930-1932.
8. Regar E, Lemos PA, Saia F, et al. Incidence of thrombotic stent occlusion during the first 3 months after sirolimus-eluting stent implantation in 500 consecutive patients. Am J Cardiol 2004;93:1271-1275.
9. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MR imaging delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
10. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223.
11. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
12. Kagetsu NJ. Litt AW. Important considerations in measurement of attractive force on metallic implants in MR imagers. Radiology 1991;179:505-508.
13. Driver over-the-wire coronary stent system [package insert]. Minneapolis, Minn: Medtronic, 2003.
14. Shellock FG, Morisoli S, Kanal E. MR procedures and biomedical implants, materials, and devices: 1993 update. Radiology 1993;189:587-599.
15. Express-2 monorail coronary stent delivery system [package insert]. Natick, Mass: Boston Scientific, 2002.
16. Multi-link pixel coronary stent systems [package insert]. Natick. Mass: Guidant/ Boston Scientific, 2003.
17. TAXUS: paclitaxel-eluting coronary stent system [package insert]. Natick, Mass: Boston Scientific, 2004.
18. CYPHER: sirolimus eluting coronary stent system [package insert.]. Miami Lakes, Fla: Cordis, 2004.
19. Gerber TC, Fasseas P, Lennon RJ, et al. Clinical safety of magnetic resonance imaging early after coronary artery stent placement. J Am Coll Cardiol 2003;42:1295-1298.
20. Kerner A, Gruberg L, Kapeliovich M, Grenadier E. Late stent thrombosis after implantation of a sirolimus-eluting stent. Catheter Cardiovasc Interv 2003;60:505-508.
21. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004;109:701-705.
22. Liistro F, Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001;86:262-264.
23. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.
24. Amado LC, Gerber BL, Gupta SN, et al. Accurate and objective infarct, sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004;44:2383-2389.
25. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation 1995;92(5):1117-1125.
26. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000;102:1678-1683,
27. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780-2783,
28. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148.
29. Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003;108:2212-2218.